Immunology Today—July 8, 2026
This week’s Immunology update highlights regulatory progress, late-stage…
Immunology Today—July 1, 2026
This week’s Immunology update highlights regulatory decisions, clinical trial…
Immunology Today—June 24, 2026
This week’s Immunology update highlights regulatory approvals, advancing late-…
Immunology Today—May 13, 2026
This week’s Immunology update highlights regulatory actions, clinical progress,…
Lucid Diligence Brief: Coultreon Biopharma Raises $125M for SIK3 Inhibitor
Lucid Diligence Brief: Coultreon Biopharma Raises $125M for SIK3 Inhibitor…
Vaccines Today—April 10, 2026
This week’s Vaccines update highlights clinical progress, early-stage trial…
Immunology Today—April 15, 2026
This week’s Immunology update highlights regulatory progress, clinical…
Immunology Today—April 8, 2026
This week’s Immunology update highlights regulatory and portfolio shifts, mid-…
Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D deal for JNJ-4804
Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D…
Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery deal
Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery…
Immunology Today—March 11, 2026
This week’s Immunology update highlights regulatory progress, positive…
Lucid Diligence Brief: Teva and Blackstone Life Sciences $400m duvakitug financing
Lucid Diligence Brief: Teva and Blackstone Life Sciences $400m duvakitug…